NO20085285L - 2-alkosy-3,4,5-tnhydroksyalkylamidbenzazepiner, deres fremstilling og bruk samt preparater inneholdende disse - Google Patents
2-alkosy-3,4,5-tnhydroksyalkylamidbenzazepiner, deres fremstilling og bruk samt preparater inneholdende disseInfo
- Publication number
- NO20085285L NO20085285L NO20085285A NO20085285A NO20085285L NO 20085285 L NO20085285 L NO 20085285L NO 20085285 A NO20085285 A NO 20085285A NO 20085285 A NO20085285 A NO 20085285A NO 20085285 L NO20085285 L NO 20085285L
- Authority
- NO
- Norway
- Prior art keywords
- benzazepines
- alkoxy
- preparation
- hydroxyalkylamide
- well
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0604733A FR2901554B1 (fr) | 2006-05-24 | 2006-05-24 | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation |
PCT/FR2007/000866 WO2007135293A2 (fr) | 2006-05-24 | 2007-05-23 | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur préparation, compositions les contenant et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20085285L true NO20085285L (no) | 2008-12-17 |
Family
ID=37487536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20085285A NO20085285L (no) | 2006-05-24 | 2008-12-17 | 2-alkosy-3,4,5-tnhydroksyalkylamidbenzazepiner, deres fremstilling og bruk samt preparater inneholdende disse |
Country Status (24)
Country | Link |
---|---|
US (1) | US7994162B2 (pt) |
EP (1) | EP2035387A2 (pt) |
JP (1) | JP2009537614A (pt) |
KR (1) | KR20090010071A (pt) |
CN (1) | CN101454290A (pt) |
AR (1) | AR061103A1 (pt) |
AU (1) | AU2007253196A1 (pt) |
BR (1) | BRPI0712925A2 (pt) |
CA (1) | CA2649336A1 (pt) |
CR (1) | CR10382A (pt) |
DO (1) | DOP2007000104A (pt) |
EA (1) | EA200870565A1 (pt) |
EC (1) | ECSP088893A (pt) |
FR (1) | FR2901554B1 (pt) |
GT (1) | GT200800249A (pt) |
IL (2) | IL194972A0 (pt) |
MA (1) | MA30561B1 (pt) |
MX (1) | MX2008014844A (pt) |
NO (1) | NO20085285L (pt) |
PE (1) | PE20080705A1 (pt) |
TN (1) | TNSN08402A1 (pt) |
TW (1) | TW200812971A (pt) |
UY (1) | UY30368A1 (pt) |
WO (1) | WO2007135293A2 (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2878528B1 (fr) | 2004-11-29 | 2008-05-16 | Aventis Pharma Sa | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation |
CN102924462B (zh) * | 2012-10-24 | 2015-01-14 | 华东师范大学 | 1,2,3,4,5,9-取代苯并吖庚因类化合物的合成方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4692522A (en) * | 1985-04-01 | 1987-09-08 | Merck & Co., Inc. | Benzofused lactams useful as cholecystokinin antagonists |
US4831135A (en) | 1986-06-18 | 1989-05-16 | The Regents Of The University Of California | Bengamide anthelmintics |
US5283241A (en) | 1992-08-28 | 1994-02-01 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
GB9411841D0 (en) | 1994-06-14 | 1994-08-03 | Pharma Mar Sa | New antitumoral compounds from jaspis sponge |
JP2002241368A (ja) | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
US6239127B1 (en) | 1999-11-17 | 2001-05-29 | Novartis Ag | Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation |
CO5140099A1 (es) | 1998-11-17 | 2002-03-22 | Novartis Ag | Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores |
CN1191237C (zh) * | 2000-05-11 | 2005-03-02 | 诺瓦提斯公司 | 取代的己内酰胺碳酸酯与醚和它们作为抗肿瘤剂的用途 |
AU2002217020A1 (en) | 2000-11-14 | 2002-05-27 | Novartis Ag | Method for screening anti-proliferative compounds and inhibiting tumor growth |
US6545148B2 (en) | 2001-03-12 | 2003-04-08 | Novartis Ag | Process for preparing certain substituted caprolactams |
JP2004262793A (ja) | 2003-02-28 | 2004-09-24 | Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai | 化合物n−9011、その製造法及び用途 |
US7378410B2 (en) * | 2003-07-25 | 2008-05-27 | Novartis Ag | Substituted lactams and their use as anti-cancer agents |
US7153846B2 (en) | 2003-10-24 | 2006-12-26 | Sanofi-Aventis Deutschland Gmbh | Bengamide derivatives, process for preparing them, and their use |
DE10349669B3 (de) | 2003-10-24 | 2005-05-25 | Aventis Pharma Deutschland Gmbh | Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
FR2878525B1 (fr) | 2004-11-29 | 2007-02-23 | Aventis Pharma Sa | Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation |
FR2878528B1 (fr) | 2004-11-29 | 2008-05-16 | Aventis Pharma Sa | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation |
-
2006
- 2006-05-24 FR FR0604733A patent/FR2901554B1/fr not_active Expired - Fee Related
-
2007
- 2007-05-17 TW TW096117596A patent/TW200812971A/zh unknown
- 2007-05-21 PE PE2007000622A patent/PE20080705A1/es not_active Application Discontinuation
- 2007-05-23 JP JP2009511545A patent/JP2009537614A/ja not_active Withdrawn
- 2007-05-23 MX MX2008014844A patent/MX2008014844A/es not_active Application Discontinuation
- 2007-05-23 EP EP07765942A patent/EP2035387A2/fr not_active Withdrawn
- 2007-05-23 CA CA002649336A patent/CA2649336A1/fr not_active Abandoned
- 2007-05-23 WO PCT/FR2007/000866 patent/WO2007135293A2/fr active Application Filing
- 2007-05-23 EA EA200870565A patent/EA200870565A1/ru unknown
- 2007-05-23 BR BRPI0712925-4A patent/BRPI0712925A2/pt not_active Application Discontinuation
- 2007-05-23 AU AU2007253196A patent/AU2007253196A1/en not_active Abandoned
- 2007-05-23 AR ARP070102222A patent/AR061103A1/es unknown
- 2007-05-23 CN CNA2007800189967A patent/CN101454290A/zh active Pending
- 2007-05-23 KR KR1020087028521A patent/KR20090010071A/ko not_active Application Discontinuation
- 2007-05-24 UY UY30368A patent/UY30368A1/es not_active Application Discontinuation
- 2007-05-24 DO DO2007000104A patent/DOP2007000104A/es unknown
-
2008
- 2008-10-15 TN TNP2008000402A patent/TNSN08402A1/en unknown
- 2008-10-20 CR CR10382A patent/CR10382A/es unknown
- 2008-10-28 IL IL194972A patent/IL194972A0/en unknown
- 2008-11-06 IL IL195148A patent/IL195148A0/en unknown
- 2008-11-10 US US12/267,689 patent/US7994162B2/en not_active Expired - Fee Related
- 2008-11-17 EC EC2008008893A patent/ECSP088893A/es unknown
- 2008-11-19 GT GT200800249A patent/GT200800249A/es unknown
- 2008-12-05 MA MA31458A patent/MA30561B1/fr unknown
- 2008-12-17 NO NO20085285A patent/NO20085285L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FR2901554B1 (fr) | 2011-04-01 |
UY30368A1 (es) | 2008-01-02 |
WO2007135293A2 (fr) | 2007-11-29 |
CA2649336A1 (fr) | 2007-11-29 |
EA200870565A1 (ru) | 2009-06-30 |
FR2901554A1 (fr) | 2007-11-30 |
TW200812971A (en) | 2008-03-16 |
IL195148A0 (en) | 2009-09-22 |
AU2007253196A1 (en) | 2007-11-29 |
GT200800249A (es) | 2009-05-15 |
ECSP088893A (es) | 2008-12-30 |
US20090099152A1 (en) | 2009-04-16 |
DOP2007000104A (es) | 2007-11-15 |
TNSN08402A1 (en) | 2010-04-14 |
WO2007135293A3 (fr) | 2008-05-02 |
PE20080705A1 (es) | 2008-07-30 |
US7994162B2 (en) | 2011-08-09 |
BRPI0712925A2 (pt) | 2013-01-08 |
AR061103A1 (es) | 2008-08-06 |
MA30561B1 (fr) | 2009-07-01 |
KR20090010071A (ko) | 2009-01-28 |
EP2035387A2 (fr) | 2009-03-18 |
JP2009537614A (ja) | 2009-10-29 |
MX2008014844A (es) | 2009-02-17 |
IL194972A0 (en) | 2009-08-03 |
CN101454290A (zh) | 2009-06-10 |
CR10382A (es) | 2009-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090295L (no) | Substituerte heteroarylderivater | |
SE0301700D0 (sv) | Novel compounds | |
NO20091299L (no) | Substituerte sulfonamidderivater | |
TW200800999A (en) | Novel compounds | |
NO20075918L (no) | Substituerte pyrrolo-pyridiner, forbindelser inneholdende disse, fremgangsmate for deres fremstilling og anvendelse derav | |
RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
IL188050A (en) | The history of azaindazole, their medicinal preparations and their uses | |
TW200745114A (en) | Novel compounds | |
BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
BRPI0809667A2 (pt) | Composto, medicamento e composição farmacêutica que o contém e uso do composto | |
EA200702589A1 (ru) | 2,6-хинолинильные производные, способы их получения и их применение | |
NO20090294L (no) | Spirocykliske azaindolderivater | |
BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
NO20081160L (no) | Benzimidazoltiofen forbindelser | |
IS2799B (is) | Kladribínefnablöndur til inngjafar um munn | |
NO20062605L (no) | Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper | |
NO20073026L (no) | 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav | |
TW200639156A (en) | New compounds | |
NO20062824L (no) | 1,3-Difenylprop-2-en-1-on-avledete forbindelser, fremgangsmater for fremstilling derav, samt anvendelse av samme | |
WO2006097617A3 (fr) | Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux | |
NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
WO2006133006A3 (en) | 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents | |
NO20065898L (no) | 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner | |
NO20064783L (no) | Opplosningstabeletter med licarbazepin | |
TW200744612A (en) | New combination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |